Hericium erinaceum (Yamabushitake) extract-induced acute respiratory distress syndrome monitored by serum surfactant proteins

Internal Medicine

Volumn 42, Issue 12, 2003, Pages 1219-1222

  Nakatsugawa, Munehide ^a   Takahashi, Hiroki ^b   Takezawa, Chikako ^a   Nakajima, Kazutaka ^a   Harada, Kazutoki ^b   Sugawara, Yoshitaka ^c   Kobayashi, Shuichi ^c   Kondo, Tatsuo ^c   Abe, Shosaku ^b  

^a Obihiro Hospital   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kyowakai Obihiro Respiratory Hospital   (Japan)

Author keywords

Acute respiratory distress syndrome; Diet food; Hericium erinaceum; Surfactant protein A; Surfactant protein D; Yamabushitake

Indexed keywords

HERICIUM ERINACEUM EXTRACT; METHYLPREDNISOLONE; PLANT EXTRACT; STEROID; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; ULINASTATIN; UNCLASSIFIED DRUG;

ACUTE RESPIRATORY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG PULSE THERAPY; FOOD INTAKE; HERICIUM ERINACEUM; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LUNG INFILTRATE; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MEDICINAL PLANT; PATHOGENESIS; PATIENT MONITORING; POSITIVE END EXPIRATORY PRESSURE; THORAX RADIOGRAPHY;

EID: 1642463420     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.1219     Document Type: Article

References (17)

1. Palmer ME, Haller C, McKinney PE, et al. Adverse events associated with dietary supplements: an observational study. Lancet 361 (9352): 101-106, 2003.
2. Takeshita K, Saisho Y, Kitamura K, et al. Pneumonitis induced by ougon (scullcap). Intern Med 40: 764-768, 2001.
3. Ohtake N, Nakai Y, Yamamoto M, et al. The herbal medicine Shosaiko-to exerts different modulating effects on lung local immune responses among mouse strains. Int Immunopharmacol 2: 357-366, 2002.
4. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824, 1994.
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245, 1981.
6. Lee EW, Shizuki K, Hosokawa S, et al. Two novel diterpenoids, crinacines H and I from the mycelia of Hericium erinaceum. Biosci Biotechnol Biochem 64: 2402-2405, 2000.
7. Braun A, Quarcoo D, Schulte-Herbruggen O, et al. Nerve growth factor induces airway hyperresponsiveness in mice. Int Arch Allergy Immunol 124: 205-207, 2001.
8. Maes MF, van Baar HM, van Ginkel CJ. Occupational allergic contact dermatitis from the mushroom White Pom Pom (Hericium erinaceum). Contact Dermatitis 40: 289-290, 1999.
9. Greene KE, Wright JR, Steinberg KP, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 160: 1843-1850, 1999.
10. Takahashi H, Fujishima T, Koba H, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162: 1109-1114, 2000.
11. Takahashi H, Kuroki Y, Tanaka H, et al Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med 162: 258-263, 2000.
12. Ohnishi H, Yokoyama A, Kondo K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 165: 378-381, 2002.
13. Ishii H, Mukae H, Kadota J, et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 58: 52-57, 2003.
14. Umetani K, Abe M, Kawabata K, et al. SP-D as a marker of amiodarone-induced pulmonary toxicity. Intern Med 41: 709-712, 2002.
15. Miyata M, Sakuma F, Fukaya E, et al. Detection and monitoring of methotrexate-associated lung injury using serum markers KL-6 and SP-D in rheumatoid arthritis. Intern Med 41: 467-473, 2002.
16. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis 133: 321-340, 1986.
17. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. Am Rev Respir Dis 133: 488-505, 1986.